NE

New Frontier Minerals Limited

Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.

NFM | IL

Overview

Corporate Details

ISIN(s):
AU0000368748
LEI:
213800AG47SZ4DGATD33
Country:
Australia
Address:
45 VENTNOR AVENUE, 6005 WEST PERTH
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

New Frontier Minerals Limited is a mineral exploration company focused on identifying and developing multi-commodity assets with the potential for economic mining operations. The company applies a disciplined and structured exploration strategy to advance its projects. Its portfolio includes assets in Australia and Zambia, with exploration focused on commodities such as heavy rare earths, niobium, uranium, and copper. A key area of current activity is the Harts Range Heavy Rare Earths and Niobium Project in Australia's Northern Territory.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 08:25
Regulatory News Service
Mining Lease Application at Big One Copper Deposit
English 25.8 KB
2025-11-10 08:10
Regulatory News Service
Drilling Campaign Approved at Harts Range Project
English 21.9 KB
2025-11-03 19:46
Regulatory News Service
Drill Targets Finalised at Harts Range Project
English 21.9 KB
2025-10-31 11:28
Pre-Annual General Meeting Information
Addendum to Notice of Annual General Meeting
English 25.2 KB
2025-10-29 11:54
Pre-Annual General Meeting Information
AGM Date & Closing Date for Director Nominations
English 12.7 KB
2025-10-09 08:00
Pre-Annual General Meeting Information
Notice of AGM
English 14.0 KB
2025-09-22 08:00
Annual Report
Final Results and Publication of Annual Report
English 615.1 KB
2025-09-22 08:00
Governance Information
Appendix G4 and Corporate Governance Statement
English 14.4 KB
2025-09-17 09:22
Delisting Announcement
Notification of Cessation of Securities
English 18.7 KB
2025-09-11 08:00
Regulatory News Service
Appointment of Drill Contractor
English 26.8 KB
2025-08-26 08:00
Report Publication Announcement
Appendix 3G
English 10.7 KB
2025-08-13 08:01
Board/Management Information
Change of Broker
English 13.4 KB
2025-08-13 08:00
Regulatory News Service
Bulk Sample from Cusp and new prospect identified
English 68.4 KB
2025-07-30 08:00
Quarterly Report
Quarterly Report
English 121.8 KB
2025-07-24 08:00
Regulatory News Service
Harts Range delivers further HRE Mineralisation
English 38.5 KB

Automate Your Workflow. Get a real-time feed of all New Frontier Minerals Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for New Frontier Minerals Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for New Frontier Minerals Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus
CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea
030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan
4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan
7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.